![Eric Bjerkholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Bjerkholt
Directeur Financier/CFO chez
MIRUM PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/05/2026
Profil
Eric Hands Claude Bjerkholt was the founder of Kenady LLC, founded in 1999, where the titles held included President, Chief Executive & Financial Officer from 1999 to 2002.
Current jobs include Independent Director at Cerus Corp.
since 2018, Director at Aimmune Therapeutics UK Ltd. since 2018, Independent Director at Surrozen, Inc. since 2023, Independent Director at Metagenomi Therapeutics, Inc. starting in 2025, and Chief Financial Officer at Mirum Pharmaceuticals, Inc. since 2023.
Former jobs include Independent Director at StemCells, Inc. from 2011 to 2016, Director at Round Table Pizza, Inc., Independent Director at Ambrx, Inc., Director at Corium LLC (Massachusetts) from 2015 to 2018, Director at Atara Biotherapeutics, Inc., Independent Director at Graybug Vision, Inc. from 2020 to 2025, Director at Structure Therapeutics, Inc., Independent Director at CalciMedica, Inc. from 2023 to 2025, Chief Financial Officer & Senior Vice President at IntraBiotics Pharmaceuticals, Inc. from 2002 to 2004, CFO, Secretary & EVP-Corporate Development at Sunesis Pharmaceuticals, Inc. from 2012 to 2017, Vice President at J.P.
Morgan & Co., Inc. (Delaware) from 1990 to 1997, Chief Financial Officer at Aimmune Therapeutics, Inc. from 2017 to 2020, and Chief Financial Officer at Chinook Therapeutics, Inc. from 2020 to 2023.
Education includes undergraduate studies at the University of Oslo and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/06/2026 | 47 181 ( 0,08 % ) | 5 M $ | 31/05/2026 | |
CERUS CORPORATION 0,13 % | 09/06/2026 | 261 679 ( 0,13 % ) | 795 504 $ | 31/05/2026 |
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
SURROZEN INC -.--% | 13/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Eric Bjerkholt
| Sociétés | Poste | Début |
|---|---|---|
| CERUS CORPORATION | Directeur/Membre du Conseil | 09/10/2018 |
| SURROZEN, INC. | Directeur/Membre du Conseil | 05/04/2023 |
| MIRUM PHARMACEUTICALS, INC. | Directeur Financier/CFO | 11/09/2023 |
| METAGENOMI THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/01/2025 |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 16/11/2018 |
Anciens postes connus de Eric Bjerkholt
| Sociétés | Poste | Fin |
|---|---|---|
| CALCIMEDICA, INC. | Directeur/Membre du Conseil | 10/01/2025 |
| CALCIMEDICA, INC. | Directeur/Membre du Conseil | 01/01/2025 |
| CHINOOK THERAPEUTICS, INC. | Directeur Financier/CFO | 01/08/2023 |
| AIMMUNE THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2020 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Eric Bjerkholt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
Round Table Pizza, Inc.
 Round Table Pizza, Inc. RestaurantsConsumer Services Owns and operates pizza franchise outlets | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Kenady LLC
 Kenady LLC Food DistributorsDistribution Services Distributes frozen meals and snacks and offers delivery services | Distribution Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
J.P. Morgan & Co., Inc. (Delaware)
 J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services | Finance |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Aimmune Therapeutics UK Ltd.
Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
